Heart Association Issues Statement on Understanding Radiation Risks Before Cardiac Imaging
|
By HospiMedica International staff writers Posted on 16 Oct 2014 |

Image: The American Heart Association issued a statement that patients need to be informed on radiation risks before undergoing cardiac imaging (Photo courtesy of AHA - The American Heart Association).
People should understand why a heart-imaging test is needed before undergoing the procedure, including the benefits and risks involved, such as the potential long-term risk from radiation exposure, advises a new scientific statement.
The statement was published online, before print, on September 29, 2014, in the American Heart Association’s (AHA; Dallas, TX, USA) journal Circulation. “When medical imaging is being considered, patients should feel very comfortable asking how the test will help them and the possible risks, including radiation-related risks,” said Reza Fazel, MD, MSc, chair of the writing committee for the statement and an AHA volunteer currently serving on the Joint Cardiac Imaging Committee of the AHA’s Council on Clinical Cardiology and Council on Cardiovascular Radiology.
As technology has evolved, imaging modalities have become an increasingly important application in diagnosing and treating patients with heart disease. However, the rising use has resulted in higher radiation exposure during the last 20 years. Heart imaging now accounts for nearly 40% of the radiation exposure patients receive from medical tests, according to the statement.
“In general, the radiation-related risk of any imaging test to an individual patient is very small and, when the test is clinically appropriate, the benefits of the test typically far outweigh any potential risks,” said Dr. Fazel, a cardiologist at Beth Israel Deaconess Medical Center (Boston, MA, USA).
Some questions that may help a patient understand the risks and benefits are: (1) how will this test help diagnose or treat my heart problem? (2) Will the results of this test change the recommended treatment? (3) Are there other techniques to get the information without using radiation? (4) How much radiation exposure may occur? (5) How could that affect my chance of developing cancer later in life? (6) Lastly, how does that risk compare to the risk from other common activities?
The most typically used heart and blood vessel imaging procedures using radiation are nuclear stress tests, cardiac computed tomography (CT) scans and fluoroscopy (a real-time X-ray technology used to guide catheter and device placement during heart catheterization and tests for heart rhythm abnormalities). Echocardiography and cardiac magnetic resonance imaging do not expose patients to ionizing radiation.
The new statement also provides guidance for the training of professionals who order or administer cardiac imaging tests. Clinicians planning imaging tests should understand when each type of test is appropriate, the typical average radiation dose and the potential risks. In deciding the best imaging method to use, the clinician should also consider the test’s diagnostic accuracy, potential risks, cost, availability, and the patient’s convenience.
“Radiation-related risk is one of the factors that should be considered in the decision to use cardiovascular imaging with ionizing radiation, particularly in younger patients in whom the potential risk of radiation exposure is thought to be higher,” Dr. Fazel said.
Clinicians who perform cardiac imaging should understand current methods required to select the optimal dose of radiation—using enough to produce high-quality imaged, not significantly more than that. They should also know how to minimize radiation exposure to staff, according to the statement.
Related Links:
American Heart Association
Beth Israel Deaconess Medical Center
The statement was published online, before print, on September 29, 2014, in the American Heart Association’s (AHA; Dallas, TX, USA) journal Circulation. “When medical imaging is being considered, patients should feel very comfortable asking how the test will help them and the possible risks, including radiation-related risks,” said Reza Fazel, MD, MSc, chair of the writing committee for the statement and an AHA volunteer currently serving on the Joint Cardiac Imaging Committee of the AHA’s Council on Clinical Cardiology and Council on Cardiovascular Radiology.
As technology has evolved, imaging modalities have become an increasingly important application in diagnosing and treating patients with heart disease. However, the rising use has resulted in higher radiation exposure during the last 20 years. Heart imaging now accounts for nearly 40% of the radiation exposure patients receive from medical tests, according to the statement.
“In general, the radiation-related risk of any imaging test to an individual patient is very small and, when the test is clinically appropriate, the benefits of the test typically far outweigh any potential risks,” said Dr. Fazel, a cardiologist at Beth Israel Deaconess Medical Center (Boston, MA, USA).
Some questions that may help a patient understand the risks and benefits are: (1) how will this test help diagnose or treat my heart problem? (2) Will the results of this test change the recommended treatment? (3) Are there other techniques to get the information without using radiation? (4) How much radiation exposure may occur? (5) How could that affect my chance of developing cancer later in life? (6) Lastly, how does that risk compare to the risk from other common activities?
The most typically used heart and blood vessel imaging procedures using radiation are nuclear stress tests, cardiac computed tomography (CT) scans and fluoroscopy (a real-time X-ray technology used to guide catheter and device placement during heart catheterization and tests for heart rhythm abnormalities). Echocardiography and cardiac magnetic resonance imaging do not expose patients to ionizing radiation.
The new statement also provides guidance for the training of professionals who order or administer cardiac imaging tests. Clinicians planning imaging tests should understand when each type of test is appropriate, the typical average radiation dose and the potential risks. In deciding the best imaging method to use, the clinician should also consider the test’s diagnostic accuracy, potential risks, cost, availability, and the patient’s convenience.
“Radiation-related risk is one of the factors that should be considered in the decision to use cardiovascular imaging with ionizing radiation, particularly in younger patients in whom the potential risk of radiation exposure is thought to be higher,” Dr. Fazel said.
Clinicians who perform cardiac imaging should understand current methods required to select the optimal dose of radiation—using enough to produce high-quality imaged, not significantly more than that. They should also know how to minimize radiation exposure to staff, according to the statement.
Related Links:
American Heart Association
Beth Israel Deaconess Medical Center
Latest Critical Care News
- Implantable Wireless Light Device Advance Bladder Cancer Treatment
- Smart Wristband Technology Detects Cardiac Arrest and Alerts Responders
- FDA-Cleared Home Sleep Test Enables Multi-Night Diagnosis of Sleep Apnea
- AI-Enabled Wearable Patches Reveal Undetected Hormone Disruption in Infertility
- AI Method Turns Toe Scan into Rapid PAD Screening Tool
- Integrated AI Pulmonary Workflow System Streamlines Detection and Follow-Up
- AI Model Predicts 10-Year Stroke Risk from Standard ECG
- Portable Ultrasound Tool Quantifies Liver Fat with MRI-Like Accuracy
- AI Tool Predicts Risk of Out-of-Hospital Cardiac Arrest
- Implantable Cytokine Device Enables Localized Immunotherapy for Ovarian Cancer
- Wearable Defibrillator Supports Quicker Beta-Blocker Optimization in Women
- High-Frequency Ultrasound Disables Viruses While Sparing Human Cells
- New Nasal Spray Enables Prehospital Neuroprotection in Ischemic Stroke
- AI-Enhanced ECG Screens for Heart Failure Risk in Resource-Limited Settings
- Single-Lead AI ECG Tool Detects Moderate-to-Severe Hyperkalemia Outside Clinic
- Reduced-Intensity Transplant Regimen Expands Donor Access in Sickle Cell Disease
Channels
Artificial Intelligence
view channel
Automated Phone Speech Test Identifies Alzheimer’s Pathology for Prescreening
Alzheimer’s disease assessment and trial recruitment often rely on costly, invasive biomarker testing and clinic-based cognitive evaluations, limiting scalability as populations age. Providers and trial... Read more
FDA-Cleared AI System Detects Sepsis Earlier and Reduces Mortality
Sepsis remains one of the deadliest complications for hospitalized patients, in part because its early signs overlap with other conditions. Each hour of delayed recognition measurably decreases survival,... Read moreCritical Care
view channel
Implantable Wireless Light Device Advance Bladder Cancer Treatment
Bladder cancer, a malignancy of the urinary bladder, often requires local therapies that spare surrounding tissue. Photodynamic therapy uses light-activated drugs but is limited by poor light penetration... Read more
AI-Enabled Wearable Patches Reveal Undetected Hormone Disruption in Infertility
Unexplained infertility, diagnosed when routine evaluations identify no clear cause, affects 15–30% of couples and often leaves patients with limited options. Standard testing typically captures hormone... Read moreSurgical Techniques
view channel
BD Launches Elyra Laser Platform for Kidney Stone and Soft Tissue Procedures
BD (Becton, Dickinson and Company) has introduced the Elyra Thulium Fiber Laser (TFL) System, an advanced laser platform developed to complete its kidney stone care portfolio for urology teams.... Read more
Stretchable Bioelectronic Implant Lowers Blood Pressure in Preclinical Study
Hypertension, or high blood pressure, drives major cardiovascular morbidity and affects nearly half of adults in the United States. About one in ten patients develop drug‑resistant hypertension that persists... Read more
FDA-Cleared Nerve Stimulator Advances Intraoperative Peripheral Nerve Assessment
The Evala Nerve Stimulator from Epineuron (Mississauga, ON, Canada) is a handheld, intraoperative electrical stimulation system designed to provide surgeons with a rapid and accurate method for nerve identification... Read morePatient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read moreHealth IT
view channel
EHR-Integrated Screening Workflow Detects Cognitive Impairment at Admission
Cognitive impairment involves difficulties with thinking, learning, memory, and decision-making, and is more common in older adults. In U.S. hospitals, more than 40% of admitted older adults have dementia,... Read more
AI System Detects and Quantifies Chronic Subdural Hematoma
Viz.ai (San Francisco, CA, USA) announced a strategic commercialization collaboration with Johnson & Johnson (New Brunswick, NJ, USA) to expand access in the United States to the Viz Subdural solution... Read more
Continuous Monitoring Platform Detects Infection Risk Across Care Transitions
Patients leaving skilled nursing facilities often lose continuous physiologic monitoring, increasing the risk of undetected infection and delayed intervention. Nursing home residents are seven times more... Read more
Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings
Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read morePoint of Care
view channel
Point-of-Care Viscoelastic Testing System Supports Obstetric Bleeding Management
HemoSonics (Durham, NC, USA) announced on May 5, 2026 that the company's Quantra Hemostasis System for Obstetric Procedures won Silver in the 2026 Edison Awards in the Women’s Health and Reproductive Innovations... Read moreBusiness
view channel
Olympus Partnership Aims to Expand Access to Robot-Assisted Endoscopic Therapy
Olympus has signed an exclusive global distribution agreement with EndoRobotics Co., Ltd., under which robot-assisted technologies developed by EndoRobotics will be distributed worldwide as part of the... Read more







